ClinicalTrials.gg
Active, not recruitingNCT04210687Updated Aug 10, 2026

Trapeziectomy vs. Trapeziometacarpal Limited Excision for Thumb Base Osteoarthritis

An interventional study of trapeziometacarpal limited excision and Trapeziectomy in Thumb Osteoarthritis, sponsored by Karolinska Institutet. Active, not recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-10.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 78 studies in Osteoarthritis with a site in Sweden — 12 open to participants now, 25 under way, none of them phase 3. Osteoarthritis · Sweden.

Planned enrollment
30th of 57
90 · median 98
Started
2020
with 4 others
No phase
41 of 78
6 open now
Primary completion
2026-12
later than 10 of 24 live
Registered
47th of 78
by date
Lead sponsor
7 of 78
Karolinska Institutet

Among the 78 studies in Osteoarthritis with a site in Sweden, this one is the 30th largest by planned enrollment of the 57 interventional ones that give a count, is one of 5 that started in 2020, is one of 41 with no phase, reaches primary completion later than 10 of the 24 other live ones, and was the 47th registered.

Osteoarthritis

2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.

Browse Osteoarthritis studies →

Open to participants now

12 of the 78 studies in Osteoarthritis with a site in Sweden are open now. Recruiting first, the newest first:

7 more — sign in →

All 12 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 78 studies in Osteoarthritis with a site in Sweden, or all of them as a file.
02

Study summary

A randomized comparison between trapeziectomy and trapeziometacarpal limited excision for thumb base osteoarthritis in 90 patients.

03

Conditions studied

  • Thumb Osteoarthritis

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Painful osteoarthritis in the thumb base and radiological arthritis (Eaton Littler class 2-3) and clinical signs of thumb base osteoarthritis (pain at palpation of the thumb base joint and pain during grinding test).
  • Pain at rest.
  • Conservative treatment >6 months (activity modification, splinting, painkillers or thumb base or PRP injection)

Exclusion criteria

Exclusion Criteria:

  • Rheumatoid arthritis.
  • Ongoing infection in the hand or wrist. -
  • History of gout or pseudo gout.
  • Inability to co-operate with the follow-up protocol (language difficulties, severe psychiatric disorder, cognitive impairment, drug addiction).
  • Intra-articular injection in the affected joint within 6 months.
  • Eaton Littler class 4 (STT joint involved).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Active comparator
    Trapeziectomy

    Standard simple trapeziectomy, no pins.

    Procedure: Trapeziectomy

  • Active comparator
    trapeziometacarpal limited excision

    Trapeziometacarpal limited excision; Narrow pseudarthrosis of the trapeziometacarpal joint.

    Procedure: trapeziometacarpal limited excision

Interventions

  • Proceduretrapeziometacarpal limited excision

    Narrow pseudarthrosis CMC1

  • ProcedureTrapeziectomy

    Simple trapeziectomy

06

What researchers measure

Primary outcomes

  1. Change in pain on load NRS (numerical rating scale)

    Change in rated pain on load from preoperatively to 1, 3 and 5 years postoperatively

    Time frame: Preoperatively, 1, 3 and 5 years postoperatively

Secondary outcomes

  1. Change in Nelson Thumb score

    0-100 p, higher score = less disability

    Time frame: Preoperatively, 1, 3 and 5 years postoperatively

  2. Change in EQ-5D

    Weight mean value: 0=dead, 1= healthy

    Time frame: 1, 3 and 5 years postoperatively

  3. Change in DASH - Disability of the Arm, Shoulder and Hand

    0-100 p, higher score = more disability

    Time frame: Preoperatively, 1, 3 and 5 years postoperatively

  4. Change in PRWHE - Patient-Rated Wrist and Hand Evaluation

    0-100 p, higher score = more disability

    Time frame: Preoperatively, 1, 3 and 5 years postoperatively

  5. Change in HADS - Change hospital Anxiety and Depression score

    2 subscores for anxiety (0-21P) and depression (0-21p), higher score = worse

    Time frame: Preoperatively, 1, 3 and 5 years postoperatively

  6. Change in PCS - Pain Catastrophizing Score

    0-52, higher score = more pain catastrophizing

    Time frame: Preoperatively, 1, 3 and 5 years postoperatively

  7. Change in Thumb base motion

    radial and palmar abduction of the first metacarpal (degrees).

    Time frame: Preoperatively, 1, 3 and 5 years postoperatively

  8. Change in thumb strength

    Key pinch and pinch strength (Kg)

    Time frame: Preoperatively, 1, 3 and 5 years postoperatively

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2020 (actual). Primary completion is estimated for Dec 2026, 80 months after the start.

Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 80 months is above that.

Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 19, 2019
First posted
Dec 26, 2019
StartActual
Mar 9, 2020
Primary completionEst.
Dec 1, 2026
CompletionEst.
May 30, 2028
Last update
Aug 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04210687
Responsible party
Maria Wilcke (Prinicipal investigator, Karolinska Institutet) — Principal investigator
First posted
Dec 26, 2019
Start date
Mar 9, 2020
Primary completion
Dec 1, 2026 (estimated)
Completion
May 30, 2028 (estimated)
Last update
Aug 10, 2026

Study contacts

Maria Wilcke, MD PhD
principal investigator · Karolinska Instituet

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion